“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pancreatic Cancer

The symposium "Hadrontherapy for Life," held in Caen, on February 10 and 11, 2025, brought together over 100 international experts of heavy ions particle therapy. Clinical aspects of current indications and future strategies were discussed. Pancreatic cancer that may reach the second cause of cancer mortality in the next decade, was prioritized. Stimulating clinical data accumulated in Japan and more recently in Europe suggest an important role for carbon ion radiotherapy (CIRT) in advanced presentations but also in a preoperative setting, at the price of acceptable toxicity. Biological aspects also plead for combinations of CIRT with bio or immune therapy.

Authors

Institutions

Publication Details

Journal
International Journal of Particle Therapy
Published
2025-11-26
DOI
https://doi.org/10.1016/j.ijpt.2025.101287
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pancreatic Cancer

Semi Harrabi, Cindy Neuzillet, Siamak Haghdoost, Tatsuya Ohno et al.
International Journal of Particle Therapy
Radiation Therapy and Dosimetry
article

“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pancreatic Cancer

Semi Harrabi, Cindy Neuzillet, Siamak Haghdoost, Tatsuya Ohno, Emily Light, Anita Mahajan, J. Doyen, Véronique Vendrely, Juliette Thariat, Shigeru Yamada, Bradford S. Hoppe, Zheng Wang, Arnold Pompoš, R. Dendale, Jean‐Louis Habrand, Dinu Stefan, Jean Lubrano
article en

Abstract

The symposium "Hadrontherapy for Life," held in Caen, on February 10 and 11, 2025, brought together over 100 international experts of heavy ions particle therapy. Clinical aspects of current indications and future strategies were discussed. Pancreatic cancer that may reach the second cause of cancer mortality in the next decade, was prioritized. Stimulating clinical data accumulated in Japan and more recently in Europe suggest an important role for carbon ion radiotherapy (CIRT) in advanced presentations but also in a preoperative setting, at the price of acceptable toxicity. Biological aspects also plead for combinations of CIRT with bio or immune therapy.

International Journal of Particle TherapyVol. 18
Mayo Clinic (US), Gunma University (JP), Heidelberg University (DE), Jacksonville College (US), University Hospital Heidelberg (DE), Centre François Baclesse (LU), National Institutes for Quantum Science and Technology (JP), Hôpital Cardiologique du Haut-Lévêque (FR), Centre François Baclesse (FR), Mayo Clinic in Arizona (US), The Christie NHS Foundation Trust (GB), Mayo Clinic in Florida (US), Centre Antoine Lacassagne (FR), Institut Curie (FR), The University of Texas Southwestern Medical Center (US), Université de Caen Normandie (FR)
Openalex Percentile: Top 45%
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.